# Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron

> **NCT03612401** · EARLY_PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 20 (actual)

## Conditions studied

- Spinal Cord Injuries
- Neurogenic Bladder
- Cognitive Change

## Interventions

- **DRUG:** Mirabegron

## Key facts

- **NCT ID:** NCT03612401
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-05
- **Primary completion:** 2020-03-23
- **Final completion:** 2021-03-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612401, "Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03612401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*